Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
- Author
- Tanvi Khera, Daniel Todt, Koen Vercauteren, C Patrick McClure, Lieven Verhoye (UGent) , Aliasghar Farhoudi Moghadam (UGent) , Sabin Bhuju, Robert Geffers, Thomas F Baumert, Eike Steinmann, Philip Meuleman (UGent) , Thomas Pietschmann and Richard JP Brown
- Organization
- Keywords
- HCV protease, Transmission, Founder populations, Longitudinal evolution, RAS emergence, HEPATITIS-C VIRUS, ANIMAL-MODELS, ENVELOPE GLYCOPROTEINS, GENETIC DIVERSITY, LIVER-DISEASE, GENOTYPE 1, INFECTION, EVOLUTION, ESCAPE, DIVERSIFICATION
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 2.55 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8523871
- MLA
- Khera, Tanvi, et al. “Tracking HCV Protease Population Diversity during Transmission and Susceptibility of Founder Populations to Antiviral Therapy.” ANTIVIRAL RESEARCH, vol. 139, 2017, pp. 129–37, doi:10.1016/j.antiviral.2017.01.001.
- APA
- Khera, T., Todt, D., Vercauteren, K., McClure, C. P., Verhoye, L., Farhoudi Moghadam, A., … Brown, R. J. (2017). Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy. ANTIVIRAL RESEARCH, 139, 129–137. https://doi.org/10.1016/j.antiviral.2017.01.001
- Chicago author-date
- Khera, Tanvi, Daniel Todt, Koen Vercauteren, C Patrick McClure, Lieven Verhoye, Aliasghar Farhoudi Moghadam, Sabin Bhuju, et al. 2017. “Tracking HCV Protease Population Diversity during Transmission and Susceptibility of Founder Populations to Antiviral Therapy.” ANTIVIRAL RESEARCH 139: 129–37. https://doi.org/10.1016/j.antiviral.2017.01.001.
- Chicago author-date (all authors)
- Khera, Tanvi, Daniel Todt, Koen Vercauteren, C Patrick McClure, Lieven Verhoye, Aliasghar Farhoudi Moghadam, Sabin Bhuju, Robert Geffers, Thomas F Baumert, Eike Steinmann, Philip Meuleman, Thomas Pietschmann, and Richard JP Brown. 2017. “Tracking HCV Protease Population Diversity during Transmission and Susceptibility of Founder Populations to Antiviral Therapy.” ANTIVIRAL RESEARCH 139: 129–137. doi:10.1016/j.antiviral.2017.01.001.
- Vancouver
- 1.Khera T, Todt D, Vercauteren K, McClure CP, Verhoye L, Farhoudi Moghadam A, et al. Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy. ANTIVIRAL RESEARCH. 2017;139:129–37.
- IEEE
- [1]T. Khera et al., “Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy,” ANTIVIRAL RESEARCH, vol. 139, pp. 129–137, 2017.
@article{8523871,
author = {{Khera, Tanvi and Todt, Daniel and Vercauteren, Koen and McClure, C Patrick and Verhoye, Lieven and Farhoudi Moghadam, Aliasghar and Bhuju, Sabin and Geffers, Robert and Baumert, Thomas F and Steinmann, Eike and Meuleman, Philip and Pietschmann, Thomas and Brown, Richard JP}},
issn = {{0166-3542}},
journal = {{ANTIVIRAL RESEARCH}},
keywords = {{HCV protease,Transmission,Founder populations,Longitudinal evolution,RAS emergence,HEPATITIS-C VIRUS,ANIMAL-MODELS,ENVELOPE GLYCOPROTEINS,GENETIC DIVERSITY,LIVER-DISEASE,GENOTYPE 1,INFECTION,EVOLUTION,ESCAPE,DIVERSIFICATION}},
language = {{eng}},
pages = {{129--137}},
title = {{Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy}},
url = {{http://doi.org/10.1016/j.antiviral.2017.01.001}},
volume = {{139}},
year = {{2017}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: